GEVO
Gevo, Inc.
GEVO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
GEVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Weak |
GEVO's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
GEVO PE Valuation
GEVO has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 101x next year's earnings.
GEVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect GEVO to return to profit, with revenue growing. However, they disagree widely on these estimates.
GEVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.78 | -$0.59 |
| Q2 2026 | -$0.90 | -$0.65 |
| Q1 2026 | -$0.14 | +$0.21 |
| Q4 2025 | -$0.14 | +$0.20 |
| Q3 2025 | -$0.19 | +$0.15 |
| Q2 2025 | -$0.25 | +$0.07 |
| Q1 2025 | -$0.35 | -$0.06 |
| Q4 2024 | -$0.34 | -$0.06 |
GEVO is still losing money, but far less than before: $0.78 per share over the past year, against $2.39 at its worst in early 2020.
GEVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $83M | +94% |
| Q2 2026 | $46.5M | +7.1% |
| Q1 2026 | $42.9M | +48% |
| Q4 2025 | $45.3M | +696% |
| Q3 2025 | $42.7M | +2074% |
| Q2 2025 | $43.4M | +725% |
| Q1 2025 | $29.1M | +630% |
| Q4 2024 | $5.7M | +30% |
GEVO's revenue has grown year over year for eight quarters in a row: $83M last quarter, up 94% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +45 points |
| Q2 2026 | -369% | -383 points |
| Q1 2026 | -11% | +58 points |
| Q4 2025 | -4.8% | +340 points |
| Q3 2025 | -8.6% | +1213 points |
| Q2 2025 | 13% | +470 points |
| Q1 2025 | -69% | +511 points |
| Q4 2024 | -345% | +143 points |
GEVO's operating margin was 36% last quarter, up 45 points from the same quarter a year ago, near the top of its range since 2019.
GEVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.2M | +$25.8M |
| Q2 2026 | -$20.8M | -$13M |
| Q1 2026 | -$30M | -$133K |
| Q4 2025 | $8.7M | +$42.2M |
| Q3 2025 | -$14.6M | +$6.2M |
| Q2 2025 | -$7.8M | +$12.9M |
| Q1 2025 | -$29.9M | +$3.7M |
| Q4 2024 | -$33.5M | -$7.8M |
GEVO has burned cash in almost every quarter: −$31M over the past year, against −$86M the year before.
GEVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 4.1x | High |
| Q4 2025 | 16.4x | High |
GEVO's net debt is about 4.1 years of its operating earnings (EBITDA).
GEVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.2 | Neutral |
| Stochastic | 49.2 | Neutral |
GEVO's weekly RSI is 59 (neutral) and its Stochastic is 49 (neutral).
GEVO PE vs Basic Materials Sector
GEVO has no meaningful PE right now: it lost money over the past year.
GEVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.36 | 37% above |
| 20 week MA | $1.49 | 25% above |
| 50 week MA | $1.77 | 5.1% above |
| 100 week MA | $1.71 | 8.8% above |
| 200 week MA | $1.47 | 27% above |
GEVO is in an uptrend: it's above all five of its weekly moving averages, and 27% above its 200-week average.
GEVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.45 | $3.70 | +51% |
| 2021 | $3.70 | $4.84 | +31% |
| 2022 | $4.84 | $1.79 | -63% |
| 2023 | $1.79 | $1.16 | -35% |
| 2024 | $1.16 | $2.10 | +81% |
| 2025 | $2.10 | $2.07 | -1.4% |
| 2026 YTD | $2.07 | $1.86 | -10% |
GEVO has finished lower in three of the last six years. It's down 10% so far in 2026.